We are live on ! Find out more

154 hedge funds and large institutions have $830M invested in CareDx in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $602K

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

42% more capital invested

Capital invested by funds: $583M → $830M (+$247M)

32% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 25

5% more funds holding

Funds holding: 147154 (+7)

3.74% less ownership

Funds ownership: 106.42%102.68% (-3.7%)

16% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 58

Holders
154
Holders Change
+7
Holders Change %
+4.76%
% of All Funds
2.22%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
33
Increased
49
Reduced
58
Closed
25
Calls
$1.5M
Puts
$602K
Net Calls
+$902K
Net Calls Change
+$457K
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$88.6M -$1.95M -161,695 -3%
BlackRock
2
BlackRock
New York
$82.1M -$1.67M -138,482 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$68M +$980K +81,116 +2%
BG
4
Bellevue Group
Switzerland
$60.8M -$259K -21,431 -0.5%
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$40M -$2.08M -172,077 -6%
NAMA
6
Nikko Asset Management Americas
New York
$40M -$2.08M -172,077 -6%
GS
7
Gagnon Securities
New York
$33.8M -$863K -71,362 -3%
Millennium Management
8
Millennium Management
New York
$33.2M +$23.7M +1,960,308 +1,085%
State Street
9
State Street
Massachusetts
$32.7M -$25.2M -2,088,510 -50%
BAMCO Inc
10
BAMCO Inc
New York
$29.1M +$7.82M +646,772 +53%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$26.8M -$3.56M -294,244 -15%
Renaissance Technologies
12
Renaissance Technologies
New York
$23.5M +$1.06M +88,100 +6%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$19.9M -$1.96M -161,890 -11%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$18.6M +$6.37K +527 +0%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$18.3M +$327K +27,068 +2%
FAM
16
Fred Alger Management
New York
$17.9M +$11.6M +963,554 +518%
First Eagle Investment Management
17
First Eagle Investment Management
New York
$15M -$442K -36,555 -4%
Morgan Stanley
18
Morgan Stanley
New York
$9.8M -$3.65M -301,715 -32%
GA
19
Gagnon Advisors
New York
$9.48M
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$9.47M -$3.14M -259,463 -30%
Bank of Montreal
21
Bank of Montreal
Ontario, Canada
$9.08M +$6.44K +533 +0.1%
BWLSA
22
Blue Water Life Science Advisors
California
$7.92M +$6.16M +510,000 New
Charles Schwab
23
Charles Schwab
California
$7.55M -$998K -82,567 -15%
Goldman Sachs
24
Goldman Sachs
New York
$7.12M -$870K -71,936 -14%
Northern Trust
25
Northern Trust
Illinois
$6.55M -$207K -17,128 -4%

CDNA Hedge Fund Activity: Q2 2024 in Review

154 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q2 2024, worth a combined $830M — up 42% from $583M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new CDNA positions and 25 closed out — a net gain of 8 holders — while 49 added to existing stakes and 58 trimmed.

The largest buyer was Millennium Management, adding an estimated $23.7M. The largest seller was State Street, cutting an estimated $25.2M.

  • 154 institutional investors held CareDx (CDNA) as of Q2 2024, up from 147 in Q1 2024.
  • Funds reported $830M of CareDx stock for Q2 2024, up 42% quarter-over-quarter.
  • 33 funds opened new CareDx positions in Q2 2024 and 25 closed out, a net change of +8 holders.
  • The largest CareDx buyer in Q2 2024 was Millennium Management, an estimated $23.7M added.
  • The largest CareDx seller in Q2 2024 was State Street, an estimated $25.2M sold.

Based on aggregated 13F filings for Q2 2024.